PANCREAS 2025 , ,
Presentations this author is a contributor to:
Prognostic Significance of ABO Blood Type in Patients with Advanced Pancreatic Cancer Treated with Nab-Paclitaxel Plus Gemcitabine (#12)
1:00 PM
Kiyotsugu Iede
Lunch & Posters 1
Clinical Significance of Increased Skeletal Muscle Mass during Nab-paclitaxel Plus Gemcitabine Treatment in Patients with Advanced Pancreatic Cancer (#33)
12:30 PM
Kiyotsugu Iede
Lunch & Posters 2